These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 15813077)

  • 1. [Cardiac aldosterone production].
    Yoshimura M
    Nihon Rinsho; 2005 Mar; 63 Suppl 3():257-62. PubMed ID: 15813077
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarction.
    Katada J; Meguro T; Saito H; Ohashi A; Anzai T; Ogawa S; Yoshikawa T
    Circulation; 2005 May; 111(17):2157-64. PubMed ID: 15851599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aldosterone].
    Yoshimura M
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():158-64. PubMed ID: 17508552
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac aldosterone synthesis?
    Emmett M
    Am J Cardiol; 2006 Apr; 97(7):1107-8. PubMed ID: 16563927
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice.
    Garnier A; Bendall JK; Fuchs S; Escoubet B; Rochais F; Hoerter J; Nehme J; Ambroisine ML; De Angelis N; Morineau G; d'Estienne P; Fischmeister R; Heymes C; Pinet F; Delcayre C
    Circulation; 2004 Sep; 110(13):1819-25. PubMed ID: 15364804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for myocardial synthesis of aldosterone producing myocardial fibrosis in man.
    Struthers AD
    Clin Sci (Lond); 2002 Apr; 102(4):387. PubMed ID: 11914099
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-genomic effects of aldosterone: new actions and questions.
    Chun TY; Pratt JH
    Trends Endocrinol Metab; 2004 Oct; 15(8):353-4. PubMed ID: 15380805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cardiac fibrosis by aldosterone.
    Lijnen P; Petrov V
    J Mol Cell Cardiol; 2000 Jun; 32(6):865-79. PubMed ID: 10888242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone-synthase overexpression in heart: a tool to explore aldosterone's effects.
    Heymes C; Garnier A; Fuchs S; Bendall JK; Nehme J; Ambroisine ML; Robidel E; Swynghedauw B; Milliez P; Delcayre C
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):213-9. PubMed ID: 15134820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Profibrotic effects of aldosterone].
    Van Den Meiracker AH; Huizenga AT; Boomsma F
    Ned Tijdschr Geneeskd; 2004 Jul; 148(31):1532-6. PubMed ID: 15366722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoids and cardiovascular diseases. Status of knowledge from experimental and clinical studies.
    Pasquale PD; Stefano GD; Paterna S
    Ital Heart J; 2000 Sep; 1(9):595-604. PubMed ID: 11130838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.
    Fiebeler A; Nussberger J; Shagdarsuren E; Rong S; Hilfenhaus G; Al-Saadi N; Dechend R; Wellner M; Meiners S; Maser-Gluth C; Jeng AY; Webb RL; Luft FC; Muller DN
    Circulation; 2005 Jun; 111(23):3087-94. PubMed ID: 15939810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarity between a substance produced by the heart in vitro and the 18-monoacetyl derivative of D-aldosterone.
    Knox JR; Lockett MF
    J Endocrinol; 1969 Feb; 43(2):315-6. PubMed ID: 5775351
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of aldosterone in the development of postinfarction fibrosis].
    Cittadini A; Serpico R; Monti MG; Saccà L
    Ital Heart J; 2005 May; 6 Suppl 1():43S-50S. PubMed ID: 15945299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone and end-organ damage.
    Marney AM; Brown NJ
    Clin Sci (Lond); 2007 Sep; 113(6):267-78. PubMed ID: 17683282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mechanisms to control aldosterone synthesis.
    Willenberg HS; Schinner S; Ansurudeen I
    Horm Metab Res; 2008 Jul; 40(7):435-41. PubMed ID: 18493881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors?
    Chai W; Hofland J; Jansen PM; Garrelds IM; de Vries R; van den Bogaerdt AJ; Feelders RA; de Jong FH; Danser AH
    J Hypertens; 2010 May; 28(5):1044-53. PubMed ID: 20179635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular and cardiac actions of aldosterone and spironolactone.
    Zannad F
    Z Kardiol; 1991; 80 Suppl 7():103-5. PubMed ID: 1792814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone modulates both the Na/H antiport and Cl/HCO3 exchanger in cultured neonatal rat cardiac cells.
    Korichneva I; Pucéat M; Millanvoye-Van Brussel E; Géraud G; Vassort G
    J Mol Cell Cardiol; 1995 Nov; 27(11):2521-8. PubMed ID: 8596202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
    Wang BH; Bertucci MC; Ma JY; Adrahtas A; Cheung RY; Krum H
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):912-8. PubMed ID: 20497423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.